News &
Events
CORPORATE ANNOUNCEMENTS & PORTFOLIO UPDATES
Stay informed on the latest product launches, regulatory milestones, corporate activities and strategic partnerships from Solaris Pharma Corporation.
News
Featured Article
Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration on for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5% in 15 g and 30 g tubes, a generic version of reference listed drug ZOVIRAX (acyclovir) Ointment 5%. For more updates, please feel free to email us info@solaris-pharma.com
Load More